Cambium Bio Limited has released a press release.
US Patent for Sygenus
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Cambium Bio
- Regeneus and Kyocera sign Progenza OA deal
- Progenza OA Kyocera negotiations update
- Kyocera completes Progenza Due Diligence
- Appendix 4C Updated
- Regeneus to be granted new key Progenza patent in U.S.
Later from Cambium Bio
- Regeneus to present at FNN Virtual Investor Event
- Appendix 4E and Annual Report
- Regeneus receives milestone payment from Kyocera
- Regeneus to be granted new Sygenus patent in Canada
- Regeneus receives $5.6M milestone payment from Kyocera
Follow Cambium Bio into a list and get an email when it puts out news.
Follow Cambium Bio